{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:25:00Z","timestamp":1788805500706,"version":"build-2803163510"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01143","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T04:33:09Z","timestamp":1558499589000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":78,"title":["\u03b2-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems"],"prefix":"10.3389","volume":"10","author":[{"given":"Yaron","family":"Ilan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00251-016-0925-y","article-title":"Glycolipid activators of invariant NKT cells as vaccine adjuvants","volume":"68","author":"Kharkwal","year":"2016","journal-title":"Immunogenetics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.coi.2013.01.003","article-title":"Transcriptional regulation of the NKT cell lineage","volume":"25","author":"Constantinides","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2018.00384","article-title":"Novel approaches to exploiting invariant NKT cells in cancer immunotherapy","volume":"9","author":"Wolf","year":"2018","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2015.00316","article-title":"Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer","volume":"6","author":"Marrero","year":"2015","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/2326-6066.CIR-15-0062","article-title":"The regulatory role of invariant NKT cells in tumor immunity","volume":"3","author":"McEwen-Smith","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fimmu.2018.00548","article-title":"CD1d-restricted type II NKT cells reactive with endogenous hydrophobic peptides","volume":"9","author":"Nishioka","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4049\/jimmunol.1601399","article-title":"Type II NKT cells and their emerging role in health and disease","volume":"198","author":"Dhodapkar","year":"2017","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fimmu.2015.00362","article-title":"The extended family of CD1d-restricted NKT cells: sifting through a mixed bag of TCRs, antigens, and functions","volume":"6","author":"Macho-Fernandez","year":"2015","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3389\/fimmu.2018.01969","article-title":"Type II NKT cells: an elusive population with immunoregulatory properties","volume":"9","author":"Singh","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2395645","DOI":"10.1155\/2016\/2395645","article-title":"Effects of invariant NKT cells on parasite infections and hygiene hypothesis","volume":"2016","author":"Yang","year":"2016","journal-title":"J Immunol Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fimmu.2015.00226","article-title":"The response of CD1d-restricted invariant NKT cells to microbial pathogens and their products","volume":"6","author":"Van Kaer","year":"2015","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.imbio.2016.11.014","article-title":"NKT cells in leishmaniasis","volume":"222","author":"Zamora-Chimal","year":"2017","journal-title":"Immunobiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5114\/ceji.2017.69361","article-title":"A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies","volume":"42","author":"Waldowska","year":"2017","journal-title":"Cent Eur J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"206731","DOI":"10.1155\/2015\/206731","article-title":"Immunoregulation of NKT cells in systemic lupus erythematosus","volume":"2015","author":"Chen","year":"2015","journal-title":"J Immunol Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1042\/CS20070328","article-title":"Hepatic NKT cells: friend or foe?","volume":"114","author":"Swain","year":"2008","journal-title":"Clin Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12929-017-0325-0","article-title":"Tailored design of NKT-stimulatory glycolipids for polarization of immune responses","volume":"24","author":"Hung","year":"2017","journal-title":"J Biomed Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fimmu.2015.00255","article-title":"Regulation of NKT cell localization in homeostasis and infection","volume":"6","author":"Slauenwhite","year":"2015","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11684-018-0622-3","article-title":"NKT cells in liver diseases","volume":"12","author":"Zhu","year":"2018","journal-title":"Front Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"G917","DOI":"10.1152\/ajpgi.00105.2005","article-title":"Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes","volume":"289","author":"Margalit","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.3748\/wjg.v13.i44.5799","article-title":"Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis","volume":"13","author":"El Haj","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/jpet.106.104950","article-title":"Glucocerebroside ameliorates the metabolic syndrome in OB\/OB mice","volume":"319","author":"Margalit","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E72","DOI":"10.1152\/ajpendo.90634.2008","article-title":"Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat","volume":"296","author":"Zigmond","year":"2009","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/JIR.S50508","article-title":"beta-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model","volume":"7","author":"Zigmond","year":"2014","journal-title":"J Inflamm Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.1073\/pnas.0908771107","article-title":"Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob\/ob mice","volume":"107","author":"Ilan","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/039463200902200406","article-title":"Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification","volume":"22","author":"Shuvy","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2249.2009.03971.x","article-title":"Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis","volume":"157","author":"Zhang","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"G1102","DOI":"10.1152\/ajpgi.00095.2016","article-title":"Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondsary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance","volume":"310","author":"Ilan","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jhep.2014.11.002","article-title":"Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity","volume":"62","author":"Anjani","year":"2015","journal-title":"J Hepatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1089\/jmf.2016.3753","article-title":"Oral administration of beta-glucosylceramide for the treatment of insulin resistance and nonalcoholic steatohepatitis: results of a double-blind, placebo-controlled trial","volume":"20","author":"Lalazar","year":"2017","journal-title":"J Med Food"},{"key":"B30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI69571","article-title":"Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients","volume":"124","author":"McDonald","year":"2014","journal-title":"J Clin Investig"},{"key":"B31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10875-009-9323-7","article-title":"Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells","volume":"30","author":"Ilan","year":"2010","journal-title":"J Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.vaccine.2008.03.026","article-title":"Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination","volume":"26","author":"Mizrahi","year":"2008","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2353\/ajpath.2009.080841","article-title":"Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2","volume":"174","author":"Lalazar","year":"2009","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/cmi.2015.115","article-title":"NKT cell subsets as key participants in liver physiology and pathology","volume":"13","author":"Bandyopadhyay","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/gut.2006.095497","article-title":"Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders","volume":"56","author":"Zigmond","year":"2007","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/01.tp.0000252783.66886.f3","article-title":"Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity","volume":"83","author":"Ilan","year":"2007","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jaut.2008.07.003","article-title":"NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids","volume":"31","author":"Zigmond","year":"2008","journal-title":"J Autoimmun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejim.2016.07.011","article-title":"Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe","volume":"37","author":"Belmatoug","year":"2017","journal-title":"Eur J Intern Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0168135","DOI":"10.1371\/journal.pone.0168135","article-title":"Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with gaucher disease","volume":"11","author":"Limgala","year":"2016","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bcmd.2013.01.001","article-title":"Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease","volume":"50","author":"Braudeau","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/8904_2014_357","article-title":"Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease","volume":"18","author":"Sotiropoulos","year":"2015","journal-title":"JIMD Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2141.2005.05503.x","article-title":"Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model","volume":"129","author":"Balreira","year":"2005","journal-title":"Br J Haematol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.imbio.2009.07.002","article-title":"Uncoupling between CD1d upregulation induced by retinoic acid and conduritol-B-epoxide and iNKT cell responsiveness","volume":"215","author":"Balreira","year":"2010","journal-title":"Immunobiology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bcmd.2016.10.015","article-title":"Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher disease","volume":"68","author":"Limgala","year":"2018","journal-title":"Blood Cells Mol Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"E3285","DOI":"10.1073\/pnas.1618133114","article-title":"Intracellular metabolite beta-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity","volume":"114","author":"Nagata","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/icb.2009.42","article-title":"Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent","volume":"87","author":"Ilan","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ajh.21369","article-title":"Enzyme replacement therapy for mild patients with Gaucher disease","volume":"84","author":"Zimran","year":"2009","journal-title":"Am J Hematol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ymgme.2008.10.001","article-title":"A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight","volume":"96","author":"Ucar","year":"2009","journal-title":"Mol Genet Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bcmd.2007.09.002","article-title":"Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy","volume":"40","author":"Langeveld","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12967-019-1798-2","article-title":"Generating randomness: making the most out of disordering a false order into a real one","volume":"17","author":"Ilan","year":"2019","journal-title":"J Transl Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1073\/pnas.012579499","article-title":"Fractal dynamics in physiology: alterations with disease and aging","volume":"99","author":"Goldberger","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1128\/AEM.01039-10","article-title":"High stability and fast recovery of expression of the TOL plasmid-carried toluene catabolism genes of Pseudomonas putida mt-2 under conditions of oxygen limitation and oscillation","volume":"76","author":"Martinez-Lavanchy","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10522-017-9680-1","article-title":"Biological ageing and clinical consequences of modern technology","volume":"18","author":"Kyriazis","year":"2017","journal-title":"Biogerontology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1023306419861","article-title":"Practical applications of chaos theory to the modulation of human ageing: nature prefers chaos to regularity","volume":"4","author":"Kyriazis","year":"2003","journal-title":"Biogerontology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/bmj.304.6820.186-c","article-title":"Chaos theory","volume":"304","author":"Kyriazis","year":"1992","journal-title":"BMJ"},{"key":"B58","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1001\/jama.1992.03480130122036","article-title":"Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence","volume":"267","author":"Lipsitz","year":"1992","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0531-5565(91)90074-V","article-title":"Applications of chaos theory to the molecular biology of aging","volume":"26","author":"Kyriazis","year":"1991","journal-title":"Exp Gerontol"},{"key":"B60","first-page":"27","article-title":"[On possible role of chaotic behavior of the gene regulation system in aging]","volume":"8","author":"Soloviev","year":"2001","journal-title":"Adv Gerontol"},{"key":"B61","first-page":"1","article-title":"Complex systems and evolutionary perspectives on organisations: the application of complexity theory to organisations","year":"2003","journal-title":"Ten Principles of Complexity and Enabling Infrastructures. Elsevier"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11157","article-title":"Randomness in microtubule dynamics: an error that requires correction or an inherent plasticity required for normal cellular function?","author":"Ilan","year":"2019","journal-title":"Cell Biol Int."},{"key":"B63","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(96)90948-4","article-title":"Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside","volume":"347","author":"Goldberger","year":"1996","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1114\/1.1481053","article-title":"Quantifying fractal dynamics of human respiration: age and gender effects","volume":"30","author":"Peng","year":"2002","journal-title":"Ann Biomed Eng"},{"key":"B65","doi-asserted-by":"publisher","first-page":"30787","DOI":"10.1038\/srep30787","article-title":"The random dot tachistogram: a novel task that elucidates the functional architecture of decision","volume":"6","author":"Genest","year":"2016","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/bulm.1998.0086","article-title":"Parkinsonian tremor and simplification in network dynamics","volume":"61","author":"Edwards","year":"1999","journal-title":"Bull Math Biol"},{"key":"B67","first-page":"629","article-title":"A quantitative study of dopamine control in the rat striatum","volume":"268","author":"Freeman","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"B68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1677\/joe.0.1580043","article-title":"Transient expression of clusterin (sulfated glycoprotein-2) during development of rat pancreas","volume":"158","author":"Min","year":"1998","journal-title":"J Endocrinol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"B115","DOI":"10.1093\/gerona\/57.3.B115","article-title":"Dynamics of stability: the physiologic basis of functional health and frailty","volume":"57","author":"Lipsitz","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02691091","article-title":"Application of chaos theory to biology and medicine","volume":"27","author":"Skinner","year":"1992","journal-title":"Integr Physiol Behav Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/rej.2005.8.96","article-title":"Clinical anti-aging hormetic strategies","volume":"8","author":"Kyriazis","year":"2005","journal-title":"Rejuvenation Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mad.2017.04.007","article-title":"Editorial: re-thinking ageing: a cross-disciplinary perspective (A New Era for Ageing)","volume":"163","author":"Kyriazis","year":"2017","journal-title":"Mech Ageing Dev"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e0156497","DOI":"10.1371\/journal.pone.0156497","article-title":"The prognostic impact of NK\/NKT cell density in periampullary adenocarcinoma differs by morphological type and adjuvant treatment","volume":"11","author":"Lundgren","year":"2016","journal-title":"PLoS ONE"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1016\/j.vaccine.2014.08.070","article-title":"Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination","volume":"32","author":"Tefit","year":"2014","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1084\/jem.20042592","article-title":"Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients","volume":"201","author":"Chang","year":"2005","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T04:33:12Z","timestamp":1558499592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2019.01143"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01143","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"article-number":"1143"}}